Subscribe to RSS
DOI: 10.1055/a-2649-9311
Survivorship Challenges and Supportive Care in Lung Cancer
Funding D.M.H. is supported by the Career Development Award (1IK2RX003661) from the United States Department of Veterans Affairs, Rehabilitation Research Development and Translation Portfolio. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the U.S. government.

Abstract
The number of lung cancer survivors—anyone living with and beyond a lung cancer diagnosis—is increasing along with advances in screening, early detection, and treatment. Following diagnosis and treatment, however, many lung cancer survivors experience high symptom burden and functional challenges that culminate in poor health-related quality of life (HRQL). We incorporated the cancer life course endorsed by the United States National Academy of Medicine (formerly Institute of Medicine) and reviewed interventions to improve HRQL, starting from the time of diagnosis, during or following curative intent treatment, noncurative intent treatment, and continued until changes in disease status and/or goals of care. We reviewed clinical guidelines from the American College of Chest Physicians on HRQL following curative intent therapy, symptom management, and supportive care in lung cancer, as well as the role of exercise-based rehabilitation, complementary therapies, and integrative medicine. Moreover, we identified interventions evaluated in 19 randomized controlled trials (RCTs) or pilot RCTs in the past 10 years, involving 2,506 participants, to address HRQL challenges reported by ≥80% of lung cancer survivors as “important” or “very important”: dyspnea, fatigue, sleep difficulties, fear/distress, anxiety, depressive symptoms, physical or role function/independence. This narrative review, which incorporates findings from physical exercise and rehabilitation, cognitive-behavioral and psychological therapies, mind-body therapies, mindfulness-based interventions, and other complementary therapies, has significant implications for enhancing the HRQL of the growing population of lung cancer survivors.
Keywords
health-related quality of life - symptom management - rehabilitation - integrative medicine - cancer survivorship - mental heath* Co-first authors.
Publication History
Accepted Manuscript online:
07 July 2025
Article published online:
30 July 2025
© 2025. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Definitions. 'Cancer Survivor' & 'Cancer Survivorship' National Cancer Institute, Division of Cancer Control & Population Sciences. Accessed March 12, 2025 at: https://cancercontrol.cancer.gov/ocs/definitions
- 2 NCCS - National Coalition for Cancer Survivorship National Coalition for Cancer Survivorship (NCCS). . Accessed March 12, 2025 at: https://canceradvocacy.org/about/our-history/
- 3 Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin 2022; 72 (01) 7-33
- 4 Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin 2021; 71 (01) 7-33
- 5 Howlader N, Forjaz G, Mooradian MJ. et al. The effect of advances in lung-cancer treatment on population mortality. N Engl J Med 2020; 383 (07) 640-649
- 6 Miller KD, Nogueira L, Devasia T. et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin 2022; 72 (05) 409-436
- 7 Wagle NS, Nogueira L, Devasia TP. et al. Cancer treatment and survivorship statistics, 2025. CA Cancer J Clin 2025; 75 (04) 308-340
- 8 Colt HG, Murgu SD, Korst RJ, Slatore CG, Unger M, Quadrelli S. Follow-up and surveillance of the patient with lung cancer after curative-intent therapy: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013; 143 (5, suppl): e437S-e454S
- 9 Vijayvergia N, Shah PC, Denlinger CS. Survivorship in non-small cell lung cancer: challenges faced and steps forward. J Natl Compr Canc Netw 2015; 13 (09) 1151-1161
- 10 Surveillance, Epidemiology, and End Results Program (SEER). Cancer Stat Facts: Lung and Bronchus Cancer. Accessed July 10, 2025 at: https://seer.cancer.gov/statfacts/html/lungb.html
- 11 Lilenbaum RC, Cashy J, Hensing TA, Young S, Cella D. Prevalence of poor performance status in lung cancer patients: implications for research. J Thorac Oncol 2008; 3 (02) 125-129
- 12 Passaro A, Spitaleri G, Gyawali B, de Marinis F. Immunotherapy in non-small-cell lung cancer patients with performance status 2: clinical decision making with scant evidence. J Clin Oncol 2019; 37 (22) 1863-1867
- 13 Gralla RJ, Hollen PJ, Msaouel P, Davis BV, Petersen J. An evidence-based determination of issues affecting quality of life and patient-reported outcomes in lung cancer: results of a survey of 660 patients. J Thorac Oncol 2014; 9 (09) 1243-1248
- 14 Zhai T, Li Y, Brown R, Lanuti M, Gainor JF, Christiani DC. Spirometry at diagnosis and overall survival in non-small cell lung cancer patients. Cancer Med 2022; 11 (24) 4796-4805
- 15 Mouronte-Roibás C, Leiro-Fernández V, Fernández-Villar A, Botana-Rial M, Ramos-Hernández C, Ruano-Ravina A. COPD, emphysema and the onset of lung cancer. A systematic review. Cancer Lett 2016; 382 (02) 240-244
- 16 Ha D, Ries AL, Montgrain P, Vaida F, Sheinkman S, Fuster MM. Time to treatment and survival in veterans with lung cancer eligible for curative intent therapy. Respir Med 2018; 141: 172-179
- 17 Bryant AK, Mundt RC, Sandhu AP. et al. Stereotactic body radiation therapy versus surgery for early lung cancer among US veterans. Ann Thorac Surg 2018; 105 (02) 425-431
- 18 Gould MK, Munoz-Plaza CE, Hahn EE, Lee JS, Parry C, Shen E. Comorbidity profiles and their effect on treatment selection and survival among patients with lung cancer. Ann Am Thorac Soc 2017; 14 (10) 1571-1580
- 19 Ha DM, Zeng C, Chan ED. et al. Association of exercise behavior with overall survival in stage I-IIIA lung cancer. Ann Am Thorac Soc 2021; 18 (06) 1034-1042
- 20 Williams CD, Alpert N, Redding IV TS. et al. Racial differences in treatment and survival among veterans and non-veterans with stage I NSCLC: An evaluation of veterans affairs and SEER-Medicare populations. Cancer Epidemiol Biomarkers Prev 2020; 29 (01) 112-118
- 21 Edwards BK, Noone AM, Mariotto AB. et al. Annual Report to the Nation on the Status of Cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer 2014; 120 (09) 1290-1314
- 22 Islam KM, Jiang X, Anggondowati T, Lin G, Ganti AK. Comorbidity and survival in lung cancer patients. Cancer Epidemiol Biomarkers Prev 2015; 24 (07) 1079-1085
- 23 Deng GE, Rausch SM, Jones LW. et al. Complementary therapies and integrative medicine in lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013; 143 (5, suppl): e420S-e436S
- 24 Campbell KL, Winters-Stone KM, Wiskemann J. et al. Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable. Med Sci Sports Exerc 2019; 51 (11) 2375-2390
- 25 From Cancer Patient to Cancer Survivor. Lost in Transition. National Research Council, Institute of Medicine; 2006. Accessed July 10, 2025 at: https://nap.nationalacademies.org/catalog/11468/from-cancer-patient-to-cancer-survivor-lost-in-transition
- 26 Mayer DK, Nasso SF, Earp JA. Defining cancer survivors, their needs, and perspectives on survivorship health care in the USA. Lancet Oncol 2017; 18 (01) e11-e18
- 27 Office of Cancer Survivorship - Survivorship Terms Definitions. National Cancer Institute- Division of Cancer Control & Population Sciences. Accessed July 10, 2025 at: https://cancercontrol.cancer.gov/ocs/definitions
- 28 Nekhlyudov L, Mollica MA, Jacobsen PB, Mayer DK, Shulman LN, Geiger AM. Developing a quality of cancer survivorship care framework: implications for clinical care, research, and policy. J Natl Cancer Inst 2019; 111 (11) 1120-1130
- 29 Ha DM. Physiologic and Patient-Centered Considerations in Lung Cancer Care. In: MacRosty CR, Rivera MP. eds. Lung Cancer: A Comprehensive Guide for the Clinician. Springer International Publishing; 2023: 277-296
- 30 WHOQOL User Manual World Health Organization (WHO) Programme on Mental Health Accessed March 12, 2025 at: https://www.who.int/publications/i/item/WHO-HIS-HSI-Rev.2012-3
- 31 Hechtner M, Eichler M, Wehler B. et al. Quality of life in NSCLC survivors - a multicenter cross-sectional study. J Thorac Oncol 2019; 14 (03) 420-435
- 32 Emery J, Butow P, Lai-Kwon J, Nekhlyudov L, Rynderman M, Jefford M. Management of common clinical problems experienced by survivors of cancer. Lancet 2022; 399 (10334): 1537-1550
- 33 Joshy G, Thandrayen J, Koczwara B. et al. Disability, psychological distress and quality of life in relation to cancer diagnosis and cancer type: population-based Australian study of 22,505 cancer survivors and 244,000 people without cancer. BMC Med 2020; 18 (01) 372
- 34 Kocarnik JM, Compton K, Dean FE. et al; Global Burden of Disease 2019 Cancer Collaboration. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019. JAMA Oncol 2022; 8 (03) 420-444
- 35 Ha D, Ries AL. Characterization of dyspnea in veteran lung cancer survivors following curative-intent therapy. J Cardiopulm Rehabil Prev 2020; 40 (02) 120-127
- 36 Komici K, Bencivenga L, Navani N. et al. Frailty in patients with lung cancer: a systematic review and meta-analysis. Chest 2022; 162 (02) 485-497
- 37 Bade BC, Zhao J, Li F. et al. Trends and predictors of quality of life in lung cancer survivors. Lung Cancer 2024; 191: 107793
- 38 Ha DM, Prochazka AV, Bekelman DB, Stevens-Lapsley JE, Studts JL, Keith RL. Modifiable factors associated with health-related quality of life among lung cancer survivors following curative intent therapy. Lung Cancer 2022; 163: 42-50
- 39 Tjong MC, Doherty M, Tan H. et al. Province-wide analysis of patient-reported outcomes for stage IV non-small cell lung cancer. Oncologist 2021; 26 (10) e1800-e1811
- 40 World Health Organization. International Classification of Functioning, Disability and Health (ICF). Accessed December, 2022 at: https://www.who.int/classifications/icf/en/
- 41 How to use the ICF - A Practical Manual for using the International Classification of Functioning, Disability and Health. World Health Organization. Accessed March 12, 2025 at: https://www.who.int/publications/m/item/how-to-use-the-icf—a-practical-manual-for-using-the-international-classification-of-functioning-disability-and-health
- 42 Donner CF, Ambrosino N, Goldstein RS. Pulmonary Rehabilitation. 2nd ed.. CRC Press; 2021
- 43 Ries AL, Ha DM. Rehabilitation in Chronic Obstructive Pulmonary Disease and Other Respiratory Disorders. In: Grippi MA, Antin-Ozerkis DE, Dela Cruz CS, Kotloff RM, Kotton CN, Pack AI. eds. Fishman's Pulmonary Diseases and Disorders, 6e. McGraw-Hill Education; 2023
- 44 Bornbaum CC, Doyle PC, Skarakis-Doyle E, Theurer JA. A critical exploration of the International Classification of Functioning, Disability, and Health (ICF) framework from the perspective of oncology: recommendations for revision. J Multidiscip Healthc 2013; 6: 75-86
- 45 Pinto M, Calafiore D, Piccirillo MC, Costa M, Taskiran OO, de Sire A. Breast cancer survivorship: the role of rehabilitation according to the International Classification of Functioning Disability and Health-a Scoping Review. Curr Oncol Rep 2022; 24 (09) 1163-1175
- 46 Simoff MJ, Lally B, Slade MG. et al. Symptom management in patients with lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013; 143 (5, suppl): e455S-e497S
- 47 Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA 1995; 273 (01) 59-65
- 48 Ha D, Mazzone PJ, Ries AL, Malhotra A, Fuster M. The utility of exercise testing in patients with lung cancer. J Thorac Oncol 2016; 11 (09) 1397-1410
- 49 Brunelli A, Kim AW, Berger KI, Addrizzo-Harris DJ. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013; 143 (5, suppl): e166S-e190S
- 50 Ford DW, Koch KA, Ray DE, Selecky PA. Palliative and end-of-life care in lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013; 143 (5, suppl): e498S-e512S
- 51 Parshall MB, Schwartzstein RM, Adams L. et al; American Thoracic Society Committee on Dyspnea. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 2012; 185 (04) 435-452
- 52 Ha DM, Deng LR, Lange AV, Swigris JJ, Bekelman DB. Reliability, validity, and responsiveness of the DEG, a three-item dyspnea measure. J Gen Intern Med 2022; 37 (10) 2541-2547
- 53 Granger CL, Connolly B, Denehy L. et al. Understanding factors influencing physical activity and exercise in lung cancer: a systematic review. Support Care Cancer 2017; 25 (03) 983-999
- 54 Kathiresan G, Clement RF, Sankaranarayanan MT. Dyspnea in lung cancer patients: a systematic review. Lung Cancer (Auckl) 2010; 1: 141-150
- 55 Ban WH, Lee JM, Ha JH. et al. Dyspnea as a prognostic factor in patients with non-small cell lung cancer. Yonsei Med J 2016; 57 (05) 1063-1069
- 56 O'Donnell DE, Banzett RB, Carrieri-Kohlman V. et al. Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable. Proc Am Thorac Soc 2007; 4 (02) 145-168
- 57 Wang Q, Stone K, Kern JA. et al. Adverse events following limited resection versus stereotactic body radiation therapy for early stage lung cancer. Ann Am Thorac Soc 2022; 19 (12) 2053-2061
- 58 Koczywas M, Williams AC, Cristea M. et al. Longitudinal changes in function, symptom burden, and quality of life in patients with early-stage lung cancer. Ann Surg Oncol 2013; 20 (06) 1788-1797
- 59 Ostroff JS, Krebs P, Coups EJ. et al. Health-related quality of life among early-stage, non-small cell, lung cancer survivors. Lung Cancer 2011; 71 (01) 103-108
- 60 Hui D, Bohlke K, Bao T. et al. Management of dyspnea in advanced cancer: ASCO guideline. J Clin Oncol 2021; 39 (12) 1389-1411
- 61 Takemura N, Cheung DST, Fong DYT. et al. Tai Chi and aerobic exercise on cancer-related dyspnea in advanced lung cancer patients: a randomized clinical trial. J Pain Symptom Manage 2024; 68 (02) 171-179
- 62 Ha DM, Comer A, Dollar B. et al. Telemedicine-based inspiratory muscle training and walking promotion with lung cancer survivors following curative intent therapy: a parallel-group pilot randomized trial. Support Care Cancer 2023; 31 (09) 546
- 63 Kendall F, Silva G, Almeida J. et al. Influence of respiratory muscle training on patients' recovery after lung resection. Int J Sports Med 2020; 41 (07) 484-491
- 64 Molassiotis A, Charalambous A, Taylor P, Stamataki Z, Summers Y. The effect of resistance inspiratory muscle training in the management of breathlessness in patients with thoracic malignancies: a feasibility randomised trial. Support Care Cancer 2015; 23 (06) 1637-1645
- 65 Turan GB, Özer Z, Sariköse A. The effects of progressive muscle relaxation exercise applied to lung cancer patients receiving chemotherapy on dyspnea, pain and sleep quality: a randomized controlled trial. Eur J Oncol Nurs 2024; 70: 102580
- 66 Johnson MJ, Kanaan M, Richardson G. et al. A randomised controlled trial of three or one breathing technique training sessions for breathlessness in people with malignant lung disease. BMC Med 2015; 13: 213
- 67 Minchom A, Punwani R, Filshie J. et al. A randomised study comparing the effectiveness of acupuncture or morphine versus the combination for the relief of dyspnoea in patients with advanced non-small cell lung cancer and mesothelioma. Eur J Cancer 2016; 61: 102-110
- 68 Milbury K, Liao Z, Shannon V. et al. Dyadic yoga program for patients undergoing thoracic radiotherapy and their family caregivers: results of a pilot randomized controlled trial. Psychooncology 2019; 28 (03) 615-621
- 69 Greer JA, Post KE, Chabria R. et al. Randomized controlled trial of a nurse-led brief behavioral intervention for dyspnea in patients with advanced lung cancer. J Clin Oncol 2024; 42 (30) 3570-3580
- 70 Takemura N, Cheung DST, Fong DYT. et al. Effectiveness of aerobic exercise and Tai Chi interventions on sleep quality in patients with advanced lung cancer: a randomized clinical trial. JAMA Oncol 2024; 10 (02) 176-184
- 71 Saligan LN, Olson K, Filler K. et al; Multinational Association of Supportive Care in Cancer Fatigue Study Group-Biomarker Working Group. The biology of cancer-related fatigue: a review of the literature. Support Care Cancer 2015; 23 (08) 2461-2478
- 72 Hung R, Krebs P, Coups EJ. et al. Fatigue and functional impairment in early-stage non-small cell lung cancer survivors. J Pain Symptom Manage 2011; 41 (02) 426-435
- 73 Carnio S, Di Stefano RF, Novello S. Fatigue in lung cancer patients: symptom burden and management of challenges. Lung Cancer (Auckl) 2016; 7: 73-82
- 74 Bade BC, Faiz SA, Ha DM. et al. Cancer-related fatigue in lung cancer: a research agenda: an official american thoracic society research statement. Am J Respir Crit Care Med 2023; 207 (05) e6-e28
- 75 Quist M, Sommer MS, Vibe-Petersen J. et al. Early initiated postoperative rehabilitation reduces fatigue in patients with operable lung cancer: a randomized trial. Lung Cancer 2018; 126: 125-132
- 76 Liu Y, Liang X, Yang B, Wu Y, Qian Y. Impact of Baduanjin Qigong exercise on fatigue in patients with lung cancer: a randomized controlled trial. J Palliat Med 2024; 27 (12) 1648-1652
- 77 Zhang LL, Wang SZ, Chen HL, Yuan AZ. Tai Chi exercise for cancer-related fatigue in patients with lung cancer undergoing chemotherapy: a randomized controlled trial. J Pain Symptom Manage 2016; 51 (03) 504-511
- 78 Zhang Q, Tang L, Chen H. et al. Psychological outcomes of the systematic interventions based on the stress-induced situation, affective, bodily, and cognitive reactions framework for patients with lung cancer: a randomized clinical trial. Int J Nurs Stud 2023; 146: 104566
- 79 Zhang Y, Liu C, Chen X, Zhang Y, Li Y, Hu X. Effects of web-based acceptance and commitment therapy on health-related outcomes among patients with lung cancer: a feasibility randomized controlled trial. Psychooncology 2024; 33 (12) e70045
- 80 Cheng CS, Chen LY, Ning ZY. et al. Acupuncture for cancer-related fatigue in lung cancer patients: a randomized, double blind, placebo-controlled pilot trial. Support Care Cancer 2017; 25 (12) 3807-3814
- 81 Hou W, Zhai L, Yang Y. et al. Is physical activity effective against cancer-related fatigue in lung cancer patients? An umbrella review of systematic reviews and meta-analyses. Support Care Cancer 2023; 31 (03) 161
- 82 Gooneratne NS, Dean GE, Rogers AE, Nkwuo JE, Coyne JC, Kaiser LR. Sleep and quality of life in long-term lung cancer survivors. Lung Cancer 2007; 58 (03) 403-410
- 83 Chen HM, Tsai CM, Wu YC, Lin KC, Lin CC. Effect of walking on circadian rhythms and sleep quality of patients with lung cancer: a randomised controlled trial. Br J Cancer 2016; 115 (11) 1304-1312
- 84 Wang YL, Zhang XF, Wang XP, Zhang YJ, Jin YY, Li WL. Combined mindfulness-based stress reduction and exercise intervention for improving psychological well-being in patients with non-small cell lung cancer. Clin Psychol Psychother 2024; 31 (04) e3023
- 85 Dai W, Feng W, Zhang Y. et al. Patient-reported outcome-based symptom management versus usual care after lung cancer surgery: a multicenter randomized controlled trial. J Clin Oncol 2022; 40 (09) 988-996
- 86 Yorke J, Johnson MJ, Punnett G. et al. Respiratory distress symptom intervention for non-pharmacological management of the lung cancer breathlessness-cough-fatigue symptom cluster: randomised controlled trial. BMJ Support Palliat Care 2024; 13 (e3): e1181-e1190
- 87 Garber CE, Greaney ML, Riebe D, Nigg CR, Burbank PA, Clark PG. Physical and mental health-related correlates of physical function in community dwelling older adults: a cross sectional study. BMC Geriatr 2010; 10: 6
- 88 Painter P, Stewart AL, Carey S. Physical functioning: definitions, measurement, and expectations. Adv Ren Replace Ther 1999; 6 (02) 110-123
- 89 Schurr T, Loth F, Lidington E. et al; European Organisation for Research, Treatment of Cancer Quality of Life Group (EORTC QLG). Patient-reported outcome measures for physical function in cancer patients: content comparison of the EORTC CAT Core, EORTC QLQ-C30, SF-36, FACT-G, and PROMIS measures using the International Classification of Functioning, Disability and Health. BMC Med Res Methodol 2023; 23 (01) 21
- 90 Efficace F, Collins GS, Cottone F. et al. Patient-reported outcomes as independent prognostic factors for survival in oncology: systematic review and meta-analysis. Value Health 2021; 24 (02) 250-267
- 91 Ha DM, Prochazka AV, Bekelman DB, Stevens-Lapsley JE, Chan ED, Keith RL. Association of leisure-time physical activity with health-related quality of life among US lung cancer survivors. JNCI Cancer Spectr 2021; 5 (01) pkaa118
- 92 Sloan JA, Cheville AL, Liu H. et al. Impact of self-reported physical activity and health promotion behaviors on lung cancer survivorship. Health Qual Life Outcomes 2016; 14: 66
- 93 Edbrooke L, Denehy L, Parry SM, Astin R, Jack S, Granger CL. How is physical activity measured in lung cancer? A systematic review of outcome measures and their psychometric properties. Respirology 2017; 22 (02) 263-277
- 94 Cavalheri V, Grigoletto I, McVeigh J. et al. Association between physical activity and reduced mortality in inoperable lung cancer. J Clin Med 2023; 12 (23) 7346
- 95 D'Silva A, Gardiner PA, Boyle T, Bebb DG, Johnson ST, Vallance JK. Associations of objectively assessed physical activity and sedentary time with health-related quality of life among lung cancer survivors: a quantile regression approach. Lung Cancer 2018; 119: 78-84
- 96 Ohri N, Halmos B, Bodner WR. et al. Daily step counts: a new prognostic factor in locally advanced non-small cell lung cancer?. Int J Radiat Oncol Biol Phys 2019; 105 (04) 745-751
- 97 Bade BC, Brooks MC, Nietert SB. et al. Assessing the correlation between physical activity and quality of life in advanced lung cancer. Integr Cancer Ther 2018; 17 (01) 73-79
- 98 Fujisawa D, Temel JS, Greer JA. et al. Actigraphy as an assessment of performance status in patients with advanced lung cancer. Palliat Support Care 2019; 17 (05) 574-578
- 99 Bade BC, Thomas DD, Scott JB, Silvestri GA. Increasing physical activity and exercise in lung cancer: reviewing safety, benefits, and application. J Thorac Oncol 2015; 10 (06) 861-871
- 100 Sanft T, Day AT, Goldman M. et al. NCCN guidelines insights: survivorship, version 2.2024. J Natl Compr Canc Netw 2024; 22 (10) 648-658
- 101 Rock CL, Thomson CA, Sullivan KR. et al. American Cancer Society nutrition and physical activity guideline for cancer survivors. CA Cancer J Clin 2022; 72 (03) 230-262
- 102 Schmitz KH, Campbell AM, Stuiver MM. et al. Exercise is medicine in oncology: engaging clinicians to help patients move through cancer. CA Cancer J Clin 2019; 69 (06) 468-484
- 103 Ha DM, Nunnery MA, Klocko RP. et al. Lung cancer survivors' views on telerehabilitation following curative intent therapy: a formative qualitative study. BMJ Open 2023; 13 (06) e073251
- 104 Liu D, Wen H, He J. et al. Society for Translational Medicine Expert Consensus on the preoperative assessment of circulatory and cardiac functions and criteria for the assessment of risk factors in patients with lung cancer. J Thorac Dis 2018; 10 (09) 5545-5549
- 105 Win T, Groves AM, Ritchie AJ, Wells FC, Cafferty F, Laroche CM. The effect of lung resection on pulmonary function and exercise capacity in lung cancer patients. Respir Care 2007; 52 (06) 720-726
- 106 Arbee-Kalidas N, Moutlana HJ, Moodley Y, Kebalepile MM, Motshabi Chakane P. The association between cardiopulmonary exercise testing and postoperative outcomes in patients with lung cancer undergoing lung resection surgery: a systematic review and meta-analysis. PLoS One 2023; 18 (12) e0295430
- 107 Sui X, Lee DC, Matthews CE. et al. Influence of cardiorespiratory fitness on lung cancer mortality. Med Sci Sports Exerc 2010; 42 (05) 872-878
- 108 Jones LW, Watson D, Herndon II JE. et al. Peak oxygen consumption and long-term all-cause mortality in nonsmall cell lung cancer. Cancer 2010; 116 (20) 4825-4832
- 109 Brunelli A, Charloux A, Bolliger CT. et al; European Respiratory Society and European Society of Thoracic Surgeons joint task force on fitness for radical therapy. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy). Eur Respir J 2009; 34 (01) 17-41
- 110 Lim E, Baldwin D, Beckles M. et al; British Thoracic Society, Society for Cardiothoracic Surgery in Great Britain and Ireland. Guidelines on the radical management of patients with lung cancer. Thorax 2010; 65 (suppl 3): iii1-iii27
- 111 Ha D, Ries AL, Lippman SM, Fuster MM. Effects of curative-intent lung cancer therapy on functional exercise capacity and patient-reported outcomes. Support Care Cancer 2020; 28 (10) 4707-4720
- 112 Ha D, Ries AL, Mazzone PJ, Lippman SM, Fuster MM. Exercise capacity and cancer-specific quality of life following curative intent treatment of stage I-IIIA lung cancer. Support Care Cancer 2018; 26 (07) 2459-2469
- 113 Holland AE, Spruit MA, Troosters T. et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J 2014; 44 (06) 1428-1446
- 114 Singh SJ, Puhan MA, Andrianopoulos V. et al. An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease. Eur Respir J 2014; 44 (06) 1447-1478
- 115 Granger CL, Denehy L, Parry SM. et al. Which field walking test should be used to assess functional exercise capacity in lung cancer? An observational study. BMC Pulm Med 2015; 15: 89
- 116 Cavalheri V, Burtin C, Formico VR. et al. Exercise training undertaken by people within 12 months of lung resection for non-small cell lung cancer. Cochrane Database Syst Rev 2019; 6 (06) CD009955
- 117 Granger CL, Edbrooke L, Antippa P. et al. Home-based exercise and self-management after lung cancer resection: a randomized clinical trial. JAMA Netw Open 2024; 7 (12) e2447325
- 118 Peddle-McIntyre CJ, Singh F, Thomas R, Newton RU, Galvão DA, Cavalheri V. Exercise training for advanced lung cancer. Cochrane Database Syst Rev 2019; 2 (02) CD012685
- 119 Edbrooke L, Aranda S, Granger CL. et al. Multidisciplinary home-based rehabilitation in inoperable lung cancer: a randomised controlled trial. Thorax 2019; 74 (08) 787-796
- 120 Bade BC, Gan G, Li F. et al. “Randomized trial of physical activity on quality of life and lung cancer biomarkers in patients with advanced stage lung cancer: a pilot study.”. BMC Cancer 2021; 21 (01) 352
- 121 Chambers SK, Baade P, Youl P. et al. Psychological distress and quality of life in lung cancer: the role of health-related stigma, illness appraisals and social constraints. Psychooncology 2015; 24 (11) 1569-1577
- 122 Morrison EJ, Novotny PJ, Sloan JA. et al. Emotional problems, quality of life, and symptom burden in lung cancer patients. Clin Lung Cancer 2017; 18 (05) 497-497
- 123 Pozo CL, Morgan MAA, Gray JE. Survivorship issues for patients with lung cancer. Cancer Control 2014; 21 (01) 40-50
- 124 Zaorsky NG, Zhang Y, Tuanquin L, Bluethmann SM, Park HS, Chinchilli VM. Suicide among cancer patients. Nat Commun 2019; 10 (01) 207-207
- 125 Arai D, Sato T, Nakachi I. et al. Longitudinal assessment of prognostic understanding in patients with advanced lung cancer and its association with their psychological distress. Oncologist 2021; 26 (12) e2265-e2273
- 126 Tian X, Jin Y, Tang L, Pi YP, Chen WQ, Jiménez-Herrera MF. Predicting the risk of psychological distress among lung cancer patients: development and validation of a predictive algorithm based on sociodemographic and clinical factors. Asia Pac J Oncol Nurs 2021; 8 (04) 403-412
- 127 Gonzalez-Ling A, Galindo Vázquez O, Espinoza Bello M. et al. Quality of life, anxiety, depression, and distress in patients with advanced and metastatic lung cancer. Palliat Support Care 2023; 21 (04) 608-615
- 128 Cataldo JK, Jahan TM, Pongquan VL. Lung cancer stigma, depression, and quality of life among ever and never smokers. Eur J Oncol Nurs 2012; 16 (03) 264-269
- 129 Chambers S, Dunn J, Scott B, Ball D. PL04.04 psychological distress and stigma for people with lung cancer: time to act. J Thorac Oncol 2021; 16 (10) S827-S828
- 130 Brown Johnson CG, Brodsky JL, Cataldo JK. Lung cancer stigma, anxiety, depression, and quality of life. J Psychosoc Oncol 2014; 32 (01) 59-73
- 131 Perloff T, King JC, Rigney M, Ostroff JS, Johnson Shen M. Survivor guilt: the secret burden of lung cancer survivorship. J Psychosoc Oncol 2019; 37 (05) 573-585
- 132 Janssens A, Derijcke S, Galdermans D. et al. Prognostic understanding and quality of life in patients with advanced lung cancer: a multicenter study. Clin Lung Cancer 2019; 20 (03) e369-e375
- 133 Hamann HA, Ver Hoeve ES, Carter-Harris L, Studts JL, Ostroff JS. Multilevel opportunities to address lung cancer stigma across the cancer control continuum. J Thorac Oncol 2018; 13 (08) 1062-1075
- 134 Lebel S, Castonguay M, Mackness G, Irish J, Bezjak A, Devins GM. The psychosocial impact of stigma in people with head and neck or lung cancer. Psychooncology 2013; 22 (01) 140-152
- 135 Chambers SK, Dunn J, Occhipinti S. et al. A systematic review of the impact of stigma and nihilism on lung cancer outcomes. BMC Cancer 2012; 12: 184-184
- 136 Hamann HA, Ostroff JS, Marks EG, Gerber DE, Schiller JH, Lee SJC. Stigma among patients with lung cancer: a patient-reported measurement model. Psychooncology 2014; 23 (01) 81-92
- 137 Hong Y, Zhang L, Liu N, Xu X, Liu D, Tu J. The central nervous mechanism of stress-promoting cancer progression. Int J Mol Sci 2022; 23 (20) 12653
- 138 Zeng Y, Hu CH, Li YZ. et al. Association between pretreatment emotional distress and immune checkpoint inhibitor response in non-small-cell lung cancer. Nat Med 2024; 30 (06) 1680-1688
- 139 Wu Y, Zhou L, Zhang X, Yang X, Niedermann G, Xue J. Psychological distress and eustress in cancer and cancer treatment: advances and perspectives. Sci Adv 2022; 8 (47) eabq7982
- 140 Ha D, Malhotra A, Ries AL, O'Neal WT, Fuster MM. Heart rate variability and heart rate recovery in lung cancer survivors eligible for long-term cure. Respir Physiol Neurobiol 2019; 269: 103264
- 141 Ha D, Fuster M, Ries AL, Wagner PD, Mazzone PJ. Heart rate recovery as a preoperative test of perioperative complication risk. Ann Thorac Surg 2015; 100 (05) 1954-1962
- 142 Ha D, Choi H, Zell K. et al. Association of impaired heart rate recovery with cardiopulmonary complications after lung cancer resection surgery. J Thorac Cardiovasc Surg 2015; 149 (04) 1168-73.e3
- 143 Ha D, Stephans K, Choi H. et al. Heart rate recovery and survival in patients undergoing stereotactic body radiotherapy for treatment of early-stage lung cancer. J Radiosurg SBRT 2015; 3 (03) 193-201
- 144 Kim K, Chae J, Lee S. The role of heart rate variability in advanced non-small-cell lung cancer patients. J Palliat Care 2015; 31 (02) 103-108
- 145 Chung KC, Muthutantri A, Goldsmith GG, Watts MR, Brown AE, Patrick DL. Symptom impact and health-related quality of life (HRQoL) assessment by cancer stage: a narrative literature review. BMC Cancer 2024; 24 (01) 884
- 146 Ha D, Kerr J, Ries AL, Fuster MM, Lippman SM, Murphy JD. A model-based cost-effectiveness analysis of an exercise program for lung cancer survivors after curative-intent treatment. Am J Phys Med Rehabil 2020; 99 (03) 233-240
- 147 Ha D, Choi H, Chevalier C, Zell K, Wang XF, Mazzone PJ. Survival in patients with metachronous second primary lung cancer. Ann Am Thorac Soc 2015; 12 (01) 79-84
- 148 Majem M, Basch E, Cella D, Garon EB, Herbst RS, Leighl NB. Understanding health-related quality of life measures used in early-stage non-small cell lung cancer clinical trials: a review. Lung Cancer 2024; 187: 107419
- 149 Eldridge SM, Lancaster GA, Campbell MJ. et al. Defining feasibility and pilot studies in preparation for randomised controlled trials: development of a conceptual framework. PLoS One 2016; 11 (03) e0150205
- 150 Eldridge SM, Chan CL, Campbell MJ. et al; PAFS consensus group. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. BMJ 2016; 355: i5239
- 151 Boutron I, Altman DG, Moher D, Schulz KF, Ravaud P. CONSORT NPT Group. CONSORT statement for randomized trials of nonpharmacologic treatments: a 2017 update and a CONSORT extension for nonpharmacologic trial abstracts. Ann Intern Med 2017; 167 (01) 40-47
- 152 Coens C, Pe M, Dueck AC. et al; Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints Data Consortium. International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium. Lancet Oncol 2020; 21 (02) e83-e96
- 153 Mandelblatt JS, Ahles TA, Lippman ME. et al. Applying a life course biological age framework to improving the care of individuals with adult cancers: review and research recommendations. JAMA Oncol 2021; 7 (11) 1692-1699
- 154 Ben-Shlomo Y. Rising to the challenges and opportunities of life course epidemiology. Int J Epidemiol 2007; 36 (03) 481-483
- 155 Survivorship. National Library of Medicine - National Center for Biotechnology Information. Accessed March 12, 2025 at: https://www.ncbi.nlm.nih.gov/mesh/2023175
- 156 Acceptance and Committment Therapy Medical Subject Headings (MeSH). National Library of Medicine - National Center for Biotechnology Information; 2014.
- 157 Acupuncture Therapy. National Library of Medicine - National Center for Biotechnology Information. Accessed March 12, 2025 at: https://www.ncbi.nlm.nih.gov/mesh/68015670
- 158 Cognitive Behavioral Therapy National Library of Medicine - National Center for Biotechnology Information. Accessed March 12, 2025 at: https://www.ncbi.nlm.nih.gov/mesh/?term=cognitive+behavioral+therapy
- 159 Complementary therapies. National Library of Medicine, National Center for Biotechnology Information. Accessed March 12, 2025 at: https://www.ncbi.nlm.nih.gov/mesh/?term=complementary+therapies
- 160 Complementary A. or Integrative Health: What's In a Name? National Institutes of Health - National Center for Complementary and Integrative Health; 2021. Accessed July 10, 2025 at: https://www.nccih.nih.gov/health/complementary-alternative-or-integrative-health-whats-in-a-name#:~:text=NCCIH's%20Role.%20NCCIH%20is%20the%20Federal%20Government's,resea rch%20on%20complementary%20and%20integrative%20health%20approaches
- 161 Integrative Medicine. National Library of Medicine, National Center for Biotechnology Information. Accessed March 12, 2025 at: https://www.ncbi.nlm.nih.gov/mesh/?term=integrative+medicine
- 162 Mind-Body Therapies. National Library of Medicine, National Center fro Biotechnology Information. Accessed March 12, 2025 at: https://www.ncbi.nlm.nih.gov/mesh/68026441
- 163 Mindfulness. National Library of Medicine, National Center for Biotechnology Information. Accessed March 12, 2025 at: https://www.ncbi.nlm.nih.gov/mesh/68064866
- 164 Kabat-Zinn J. Full Catastrophe Living. Bantam; Revised edition (September 24, 2013); 2013
- 165 Mindfulness-Based Stress Reduction. National Library of Medicine, National Center for Biotechnology Information. Accessed March 12, 2025 at: https://www.ncbi.nlm.nih.gov/mesh/?term=mbsr
- 166 Palliative Care. World Health Organization (WHO). Accessed July 10, 2025 at: https://www.who.int/news-room/fact-sheets/detail/palliative-care
- 167 Holistic health. National Library of Medicine, National Center for Biotechnology Information. Accessed March 12, 2025 at: https://www.ncbi.nlm.nih.gov/mesh/68006694
- 168 Yoga. National Library of Medicine, National Center for Biotechnology Information. Accessed March 12, 2025 at: https://www.ncbi.nlm.nih.gov/mesh/68015013